---
title: Investigating Cell-Free DNA in Liquid Biopsy
description: "Download this whitepaper to learn more about:\n\nLimitations of a tissue biopsy \nThe challenges and advantages of using cfDNA\nHow library preparation has advanced to tackle sample bottlenecks"
image: https://go.technologynetworks.com/hubfs/Technology%20Networks/Landing%20Pages/Cytiva/January%202023/Cytiva%20-%20green%20and%20blue.png
---

![TN_Stacked_White](https://go.technologynetworks.com/hubfs/Technology%20Networks/Logos/TN_Stacked_White.png "TN_Stacked_White")

![TN_Stacked_White](https://go.technologynetworks.com/hubfs/Technology%20Networks/Logos/TN_Stacked_White.png "TN_Stacked_White")

![TN_Stacked_White-1](https://go.technologynetworks.com/hubfs/Imported%20images/TN_Stacked_White-1.png "TN_Stacked_White-1")

Whitepaper

# Investigating Cell-Free DNA in Liquid Biopsy

![Investigating-liquid-biopsy-banner-600x280-CY33502-18Dec22-BN](https://go.technologynetworks.com/hs-fs/hubfs/Technology%20Networks/Landing%20Pages/Cytiva/January%202023/Investigating-liquid-biopsy-banner-600x280-CY33502-18Dec22-BN.jpg?width=450&height=210&name=Investigating-liquid-biopsy-banner-600x280-CY33502-18Dec22-BN.jpg)

Only a small amount of cell-free DNA (cfDNA) can be found in circulation, therefore efficient and highly sensitive technologies such as next-generation sequencing (NGS) are typically being used to detect this biomarker. 

However, NGS is not without its challenges. If genomic DNA is released from lysed or apoptotic cells, this can contaminate the cfDNA in the sample. 

This whitepaper discusses the challenges and opportunities in measuring cfDNA from liquid samples. 

**Download this whitepaper to learn more about:**

- Limitations of a tissue biopsy 
- The challenges and advantages of using cfDNA
- How library preparation has advanced to tackle sample bottlenecks

**Brought to you by:**

 

**![cytiva_logo-1](https://go.technologynetworks.com/hs-fs/hubfs/LabManager/Webinars/Registration%20Pages/2020-11-12%20Managing%20HCP%20Risk%20Requires%20a%20Multifactor%20Approach/cytiva_logo-1.png?width=164&name=cytiva_logo-1.png)**

 

  
**Download this whitepaper to learn more about:**

- Limitations of a tissue biopsy 
- The challenges and advantages of using cfDNA
- How library preparation has advanced to tackle sample bottlenecks 

Access this whitepaper for FREE Now!

Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.

![TN_Stacked](https://go.technologynetworks.com/hubfs/Imported%20images/TN_Stacked.svg "TN_Stacked")

Technology Networks Limited   
Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK   
Email: privacy@technologynetworks.com   
© 2023 Technology Networks. All rights reserved

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy](https://www.technologynetworks.com/tn/privacy)

This content is copyright protected. Any public or private use of this content is subject to prevailing copyright laws. Please contact [Technology Networks](https://www.technologynetworks.com/tn/copyright) for permission requests.